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Evidence suggests that transdifferentiation of
mesenchymal stem cells (MSCs) into various
neuronal cells contributes to functional recovery
after experimental spinal cord injury. Qiu et al. have
recently published an exciting article in Stem Cell
Research & Therapy demonstrating the transdifferentiation
of already differentiated MSCs that contributes to
remyelination of injured/regenerating axons, and thereby
to functional recovery of spinal cord injured animals. The
authors highlight the importance of interaction between
neurotrophin-3 and tropomyosin receptor kinase C for
the observed effects. This study provided important
evidence that manipulation of rat bone marrow-derived
MSCs before transplantation could enhance the
therapeutic benefit of cell-based treatment.rMSCs was positive for astrocyte and oligodendrocyteIntroduction
Despite exciting progress in the field of regeneration,
functional remyelination has not been demonstrated in
the adult injured central nervous system. For trans-
planted mesenchymal stem cells (MSCs) to effectively
reverse traumatic spinal cord injury (SCI), multiple bar-
riers have to be overcome such as low survival of trans-
planted MSCs, limited neuronal transdifferentiation,
remyelination, synaptogenesis, and, not least of all, gliosis.
Regardless of the source of MSCs (adipose, bone marrow,
or umbilical cord blood), cell-based therapy appeared to
be promising in mitigating the extent of SCI, promoting
neuronal repair and regeneration. Even though our
laboratory has demonstrated the ability of MSCs to
transdifferentiate and remyelinate injured axons, the* Correspondence: krishnav@uic.edu
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Main text
Several recent studies have shown that manipulated
Schwann cells (SCs) and MSCs which overexpressed
neurotrophin-3 (NT-3) and tropomyosin receptor kinase
C (TrkC), alone or in concert in co-cultured milieu, pro-
moted survivability, neuronal transdifferentiation, remyeli-
nation, and synaptogenesis and attenuated the gliosis
process [4–8]. This study by Qiu et al. [9] used only
MSCs, instead of mixed SCs and MSCs as used in other
studies. The rat mesenchymal stem cells (rMSCs) were
genetically manipulated to overexpress either NT-3 or its
high-affinity receptor TrkC and allowed the cells to differ-
entiate in a three-dimensional gelatin sponge scaffold.
Fourteen days after culture in the scaffold, none of the
markers. More than 70 % of either manipulated or non-
manipulated rMSCs expressed immature neuronal
markers. However, only 7 % of the nonmanipulated
rMSCs transdifferentiated into mature neuronal marker,
as compared with 44 % and 45 % in NT-3-overexpressed
rMSCs and TrkC-overexpressed rMSCs, respectively. The
percentage of rMSCs positive for mature neuronal marker
increased to 68 % (p < 0.05 vs. other groups) when
NT-3-overexpressing and TrkC-overexpressing rMSCs
were cultured together. This study highlighted the im-
portance of NT-3/TrkC interaction in improving the
transdifferentiating potential of rMSCs to neural-like
cells. Although these results are interesting, we still
do not understand why the nonmanipulated rMSCs
were positive only for immature neuronal marker and
not for astrocyte or oligodendrocyte markers.
NT-3 is a member of one of the four known neurotro-
phins, which include nerve growth factor, brain-derived
neurotrophic factor, and neurotrophin 4/5. NT-3 acts
very strongly on neurons within the corticospinal tract
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and plasticity of synapses [11]. Binding of NT-3 to TrkC
also induces phosphorylation of intracellular tyrosine
residues that block caspase activation associated with
cell death [12]. Qiu et al. have provided evidence that
NT-3/TrkC binding caused the transdifferentiation of
already differentiated rMSCs in the injured rat spinal
cord. The most interesting outcome of this study is the
transdifferentiation of rMSC-derived neural-like cells
into myelin-forming cells after their transplantation in
the injured rat spinal cord. Here, the authors highlighted
the importance and contribution of NT-3/TrkC inter-
action to the loss of neural phenotypes in rMSC-derived
neural-like cells, the transdifferentiation of the differenti-
ated rMSCs into myelin-forming cells, the formation of
myelin sheaths around the injured/regenerating axons,
and the locomotor recovery of spinal cord injured rats.
However, the authors did not elucidate the underlying
mechanism of transdifferentiation of already differenti-
ated cells. It could be speculated that the local micro-
environment of the demyelinated region may be more
conducive to induce the transdifferentiation of rMSC-
derived neural-like cells into oligodendrocytes. An-
other study published by the same group of researchers
demonstrated that the addition of exogenous NT-3
into the cultured TrkC-overexpressing rMSCs pro-
moted their transdifferentiation into oligodendrocytes
[7]. Currently, we do not know why NT-3/TrkC bind-
ing in vitro led to transdifferentiation of TrkC-
overexpressing rMSCs into myelin-forming cells and
the associated mechanisms. It is possible that binding
of NT-3/TrkC activates downstream signaling of the
mitogen-activated protein kinase kinase (MEK) –extra-
cellular signal-regulated kinase (ERK) pathway [13].
Conclusions
Further studies are warranted to better understand the
underlying molecular mechanisms of NT-3/TrkC signal-
ing that leads to transdifferentiation of MSCs.
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